After 50 years of practice with excellence in hematopathology, and laboratory medicine, the idea of enhancing our scope of specialization rise up to involve the new emerging field in pathology which is the Molecular Pathology and Cytogenetic studies.
+ (123) 1800-453-1546
info@example.com

Related Posts

FISH t(15;17) PML/RARA

TEST NAME

– FISH t(15;17) PML/RARA
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
ABOUT TEST

– Acute myeloid leukemia (AML) refers to a group of hematopoietic neoplasms involving cells committed to the myeloid lineage. Acute promyelocytic leukemia (APL) is a biologically and clinically distinct variant of AML. APL was classified as AML-M3 in the older French-American-British (FAB) classification system and is currently classified as acute promyelocytic leukemia with t(15;17)(q24.1;q21.1); PML-RARA in the latest WHO classification system.
The cytogenetic hallmark of APL is a translocation involving the retinoic acid receptor-alpha (RAR-alpha, RARa) locus on chromosome 17. The vast majority of these cases contain t(15;17)(q24.1;q21.1), although several variant translocations involving RARa have been identified, including t(11;17) and t(5;17). Distinguishing between these translocations is important because patients with the variant translocation t(11;17) are almost invariably resistant to ATRA.
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
GENES TESTED

– t(15;17) (q24;q21)
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
SAMPLE REQUIREMENTS

– Green
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
TAT

– 10
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
Related Tests

– FISH t(8;21) AML/ETO
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ